1. Home
  2. CGEN
  3. CGEN News

Latest Compugen Ltd. (CGEN) News on January 19, 2025

Compugen Announces First Patient Dosed in Phase 1 Clinical Trial to Evaluate COM503 as Monotherapy and in Combination with Zimberelimab in Advanced Solid Tumors
CGEN

PR Newswire

11 days ago

Compugen Announces First Patient Dosed in Phase 1 Clinical Trial to Evaluate COM503 as Monotherapy and in Combination with Zimberelimab in Advanced Solid Tumors

The past five years for Compugen (NASDAQ:CGEN) investors has not been profitable
CGEN

Simply Wall St.

24 days ago

The past five years for Compugen (NASDAQ:CGEN) investors has not been profitable

Compugen Expands its Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use of COM902 (reduced Fc anti-TIGIT) with anti-PD-1 and anti-PVRIG Antibodies
CGEN

PR Newswire

2 months ago

Compugen Expands its Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use of COM902 (reduced Fc anti-TIGIT) with anti-PD-1 and anti-PVRIG Antibodies

Compugen Ltd. (NASDAQ:CGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
CGEN

Simply Wall St.

2 months ago

Compugen Ltd. (NASDAQ:CGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Compugen Ltd (CGEN) Q3 2024 Earnings Call Highlights: Promising Developments and Strategic ...
CGEN

GuruFocus.com

2 months ago

Compugen Ltd (CGEN) Q3 2024 Earnings Call Highlights: Promising Developments and Strategic ...

Compugen (CGEN) Q3 Earnings and Revenues Lag Estimates
CGEN

Zacks

2 months ago

Compugen (CGEN) Q3 Earnings and Revenues Lag Estimates

CGEN

Associated Press Finance

2 months ago

Compugen: Q3 Earnings Snapshot

Compugen Reports Third Quarter 2024 Results
CGEN

PR Newswire

2 months ago

Compugen Reports Third Quarter 2024 Results

Compugen to Participate in Stifel 2024 Healthcare Conference
CGEN

PR Newswire

2 months ago

Compugen to Participate in Stifel 2024 Healthcare Conference

Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and Pembrolizumab Combination in Patients with Platinum Resistant Ovarian Cancer at SITC 2024
CGEN

PR Newswire

2 months ago

Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and Pembrolizumab Combination in Patients with Platinum Resistant Ovarian Cancer at SITC 2024

Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
CGEN

PR Newswire

3 months ago

Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Compugen Gears Up to Report Q3 Earnings: Here's What to Expect
CGEN

Zacks

3 months ago

Compugen Gears Up to Report Q3 Earnings: Here's What to Expect

Compugen to Present New Clinical Data at SITC 2024
CGEN

PR Newswire

3 months ago

Compugen to Present New Clinical Data at SITC 2024

Compugen (CGEN) Upgraded to Strong Buy: What Does It Mean for the Stock?
CGEN

Zacks

4 months ago

Compugen (CGEN) Upgraded to Strong Buy: What Does It Mean for the Stock?

Compugen to Present at Single Cell Genomics 2024 Conference
CGEN

PR Newswire

4 months ago

Compugen to Present at Single Cell Genomics 2024 Conference

Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference
CGEN

PR Newswire

5 months ago

Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Can Compugen (CGEN) Run Higher on Rising Earnings Estimates?
CGEN

Zacks

5 months ago

Can Compugen (CGEN) Run Higher on Rising Earnings Estimates?

Party Time: Brokers Just Made Major Increases To Their Compugen Ltd. (NASDAQ:CGEN) Earnings Forecasts
CGEN

Simply Wall St.

5 months ago

Party Time: Brokers Just Made Major Increases To Their Compugen Ltd. (NASDAQ:CGEN) Earnings Forecasts

Compugen Ltd. (NASDAQ:CGEN): When Will It Breakeven?
CGEN

Simply Wall St.

5 months ago

Compugen Ltd. (NASDAQ:CGEN): When Will It Breakeven?

Compugen (CGEN) Reports Q2 Loss, Tops Revenue Estimates
CGEN

Zacks

5 months ago

Compugen (CGEN) Reports Q2 Loss, Tops Revenue Estimates

CGEN

Associated Press Finance

5 months ago

Compugen: Q2 Earnings Snapshot

Compugen Reports Second Quarter 2024 Results
CGEN

PR Newswire

5 months ago

Compugen Reports Second Quarter 2024 Results

Compugen receives FDA approval for Phase I trial of solid tumour treatment
CGEN

Clinical Trials Arena

6 months ago

Compugen receives FDA approval for Phase I trial of solid tumour treatment

CGEN

MT Newswires

6 months ago

Compugen Gets US FDA Approval for Solid Tumor Treatment Study

Compugen Announces FDA Clearance of IND for COM503 for the Treatment of Solid Tumors
CGEN

PR Newswire

6 months ago

Compugen Announces FDA Clearance of IND for COM503 for the Treatment of Solid Tumors

Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024
CGEN

PR Newswire

6 months ago

Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024

Lexeo (LXEO) Down Despite Upbeat Rare Disease Gene Therapy Data
CGEN

Zacks

6 months ago

Lexeo (LXEO) Down Despite Upbeat Rare Disease Gene Therapy Data

Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why
CGEN

Zacks

6 months ago

Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why

Indivior (INDV) Down on Dropping Schizophrenia Drug, Cuts '24 View
CGEN

Zacks

6 months ago

Indivior (INDV) Down on Dropping Schizophrenia Drug, Cuts '24 View

The past three years for Compugen (NASDAQ:CGEN) investors has not been profitable
CGEN

Simply Wall St.

7 months ago

The past three years for Compugen (NASDAQ:CGEN) investors has not been profitable

Compugen to Present at Upcoming Antibody Industrial Symposium
CGEN

PR Newswire

7 months ago

Compugen to Present at Upcoming Antibody Industrial Symposium

Lotto 6/49 - $64 million up for grabs in the next draw!
CGEN

CNW Group

7 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
CGEN

Simply Wall St.

7 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
CGEN

AFP

7 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
CGEN

Simply Wall St.

7 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
CGEN

Simply Wall St.

7 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
CGEN

Barrons.com

7 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
CGEN

Simply Wall St.

7 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
CGEN

Simply Wall St.

7 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Compugen (CGEN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
CGEN

Zacks

7 months ago

Compugen (CGEN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig
CGEN

PR Newswire

8 months ago

Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig

Earnings Release: Here's Why Analysts Cut Their Compugen Ltd. (NASDAQ:CGEN) Price Target To US$5.00
CGEN

Simply Wall St.

8 months ago

Earnings Release: Here's Why Analysts Cut Their Compugen Ltd. (NASDAQ:CGEN) Price Target To US$5.00

Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates
CGEN

Zacks

8 months ago

Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates

CGEN

Associated Press Finance

8 months ago

Compugen: Q1 Earnings Snapshot

Compugen Reports First Quarter 2024 Results
CGEN

PR Newswire

8 months ago

Compugen Reports First Quarter 2024 Results

Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential
CGEN

PR Newswire

8 months ago

Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential

CGEN

MT Newswires

8 months ago

Compugen Names David Silberman CFO

Compugen Appoints David Silberman as Chief Financial Officer
CGEN

PR Newswire

8 months ago

Compugen Appoints David Silberman as Chief Financial Officer

Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024
CGEN

PR Newswire

8 months ago

Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024

We're Not Worried About Compugen's (NASDAQ:CGEN) Cash Burn
CGEN

Simply Wall St.

9 months ago

We're Not Worried About Compugen's (NASDAQ:CGEN) Cash Burn

Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024
CGEN

PR Newswire

9 months ago

Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024

Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503
CGEN

PR Newswire

9 months ago

Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503

Compugen to Participate in Two Upcoming Investor Conferences
CGEN

PR Newswire

10 months ago

Compugen to Participate in Two Upcoming Investor Conferences

Is Compugen Ltd. (NASDAQ:CGEN) Trading At A 31% Discount?
CGEN

Simply Wall St.

10 months ago

Is Compugen Ltd. (NASDAQ:CGEN) Trading At A 31% Discount?

Are You Looking for a Top Momentum Pick? Why Compugen (CGEN) is a Great Choice
CGEN

Zacks

10 months ago

Are You Looking for a Top Momentum Pick? Why Compugen (CGEN) is a Great Choice

Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy
CGEN

PR Newswire

10 months ago

Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy

Compugen Ltd. (NASDAQ:CGEN) Q4 2023 Earnings Call Transcript
CGEN

Insider Monkey

10 months ago

Compugen Ltd. (NASDAQ:CGEN) Q4 2023 Earnings Call Transcript

Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024
CGEN

PR Newswire

10 months ago

Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024

Compugen Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
CGEN

Simply Wall St.

10 months ago

Compugen Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

CGEN

Associated Press Finance

10 months ago

Compugen: Q4 Earnings Snapshot

Compugen Reports Fourth Quarter and Full Year 2023 Results
CGEN

PR Newswire

10 months ago

Compugen Reports Fourth Quarter and Full Year 2023 Results

Is a Surprise Coming for Compugen (CGEN) This Earnings Season?
CGEN

Zacks

a year ago

Is a Surprise Coming for Compugen (CGEN) This Earnings Season?

ACM Research (ACMR) to Report Q4 Earnings: What's in Store?
CGEN

Zacks

a year ago

ACM Research (ACMR) to Report Q4 Earnings: What's in Store?

Compugen to Present at the Leerink Partners Global Biopharma Conference 2024
CGEN

PR Newswire

a year ago

Compugen to Present at the Leerink Partners Global Biopharma Conference 2024

Compugen (CGEN) is a Great Momentum Stock: Should You Buy?
CGEN

Zacks

a year ago

Compugen (CGEN) is a Great Momentum Stock: Should You Buy?

Compugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024
CGEN

PR Newswire

a year ago

Compugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024

Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer
CGEN

PR Newswire

a year ago

Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer

AMMO Insider Ups Holding During Year
CGEN

Simply Wall St.

a year ago

AMMO Insider Ups Holding During Year

Colony Bankcorp to Participate in Janney Annual CEO Forum
CGEN

Business Wire

a year ago

Colony Bankcorp to Participate in Janney Annual CEO Forum

CGEN

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/29/2024

First Hawaiian, Inc. (NASDAQ:FHB) Q4 2023 Earnings Call Transcript
CGEN

Insider Monkey

a year ago

First Hawaiian, Inc. (NASDAQ:FHB) Q4 2023 Earnings Call Transcript

Colony Bankcorp, Inc. (NASDAQ:CBAN) Q4 2023 Earnings Call Transcript
CGEN

Insider Monkey

a year ago

Colony Bankcorp, Inc. (NASDAQ:CBAN) Q4 2023 Earnings Call Transcript

Chemung Financial Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
CGEN

Simply Wall St.

a year ago

Chemung Financial Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Is LSI Industries Inc. (NASDAQ:LYTS) Trading At A 44% Discount?
CGEN

Simply Wall St.

a year ago

Is LSI Industries Inc. (NASDAQ:LYTS) Trading At A 44% Discount?

CGEN

Associated Press Finance

a year ago

FVCBankcorp: Q4 Earnings Snapshot

FVCBankcorp, Inc. Announces 2023 Earnings
CGEN

Business Wire

a year ago

FVCBankcorp, Inc. Announces 2023 Earnings

Maxeon Solar Technologies Recognized as One of the World's Top 50 Most Sustainable Corporations
CGEN

PR Newswire

a year ago

Maxeon Solar Technologies Recognized as One of the World's Top 50 Most Sustainable Corporations

CGEN

Associated Press Finance

a year ago

Capital Bancorp: Q4 Earnings Snapshot

Capital Bancorp, Inc. Reports Fourth Quarter 2023 Net Income of $9.0 million, or $0.65 per share
CGEN

GlobeNewswire

a year ago

Capital Bancorp, Inc. Reports Fourth Quarter 2023 Net Income of $9.0 million, or $0.65 per share

Shareholders in Kandi Technologies Group (NASDAQ:KNDI) are in the red if they invested three years ago
CGEN

Simply Wall St.

a year ago

Shareholders in Kandi Technologies Group (NASDAQ:KNDI) are in the red if they invested three years ago

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
CGEN

Business Wire

a year ago

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

The Lovesac Company's (NASDAQ:LOVE) Stock Is Going Strong: Is the Market Following Fundamentals?
CGEN

Simply Wall St.

a year ago

The Lovesac Company's (NASDAQ:LOVE) Stock Is Going Strong: Is the Market Following Fundamentals?

EV Stock Investors Can't Ignore the Latest Industry Warning Sign
CGEN

Motley Fool

a year ago

EV Stock Investors Can't Ignore the Latest Industry Warning Sign

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing
CGEN

PR Newswire

a year ago

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing

Are Medical Stocks Lagging Amarin (AMRN) This Year?
CGEN

Zacks

a year ago

Are Medical Stocks Lagging Amarin (AMRN) This Year?

Amarin (AMRN) Stock Rises on Stellar Q4 Preliminary Results
CGEN

Zacks

a year ago

Amarin (AMRN) Stock Rises on Stellar Q4 Preliminary Results

Data Analytics Stocks Q3 Recap: Benchmarking Domo (NASDAQ:DOMO)
CGEN

StockStory

a year ago

Data Analytics Stocks Q3 Recap: Benchmarking Domo (NASDAQ:DOMO)

Q3 Earnings Highs And Lows: Amplitude (NASDAQ:AMPL) Vs The Rest Of The Data Analytics Stocks
CGEN

StockStory

a year ago

Q3 Earnings Highs And Lows: Amplitude (NASDAQ:AMPL) Vs The Rest Of The Data Analytics Stocks

What Does American Woodmark Corporation's (NASDAQ:AMWD) Share Price Indicate?
CGEN

Simply Wall St.

a year ago

What Does American Woodmark Corporation's (NASDAQ:AMWD) Share Price Indicate?

Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
CGEN

PR Newswire

a year ago

Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer

Destination XL Group, Inc. Reports Holiday Sales Results
CGEN

GlobeNewswire

a year ago

Destination XL Group, Inc. Reports Holiday Sales Results

Compugen Regains Compliance with Nasdaq Minimum Bid Price Requirement
CGEN

PR Newswire

a year ago

Compugen Regains Compliance with Nasdaq Minimum Bid Price Requirement

CGEN

Market Exclusive

a year ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Ecstasy-for-Medicine Advocate Raises $100 Million
CGEN

The Wall Street Journal

a year ago

Ecstasy-for-Medicine Advocate Raises $100 Million

Kymera Therapeutics Announces Pricing of $275 Million Public Offering
CGEN

GlobeNewswire

a year ago

Kymera Therapeutics Announces Pricing of $275 Million Public Offering

Why Semler Scientific, Inc. (NASDAQ:SMLR) Could Be Worth Watching
CGEN

Simply Wall St.

a year ago

Why Semler Scientific, Inc. (NASDAQ:SMLR) Could Be Worth Watching

Kymera Therapeutics Announces Proposed Public Offering
CGEN

GlobeNewswire

a year ago

Kymera Therapeutics Announces Proposed Public Offering

Invesco Mortgage Capital (IVR) Dips More Than Broader Market: What You Should Know
CGEN

Zacks

a year ago

Invesco Mortgage Capital (IVR) Dips More Than Broader Market: What You Should Know

CGEN

GlobeNewswire

a year ago

The Lovesac Company Announces Participation in the 2024 ICR Conference

Founder and CEO of The Lovesac Company Publishes Candid Origin Story
CGEN

PR Newswire

a year ago

Founder and CEO of The Lovesac Company Publishes Candid Origin Story

Share on Social Networks: